IV. Epidemiology: Consulting, collaboration, and independent
studies
NCCC has been and has the experience and expertise to be involved in the following:
1. Study design: case-control, intervention, cohort, randomized clinical trials and other designs
2. Defining study power to ensure compliance with FDA requirements
3. Development of a statistical plan either before or after the study is in the field
4. Statistical analysis of study results after the data has been collected
5. Design of operations manuals
6. Train staff in data collection methods
7. Design of questionnaires (both hard copy and web-based)
8. Conduct of focus groups and analysis of collected information
9. Translation and validation of study materials into multiple languages
10. Patient identification*
11. Identification of people without the disease (controls) and matching controls to cases on specific characteristics (age, gender etc…)
12. Identification and recruitment of families at high risk for specific cancers
13. Enrollment of patients and controls into studies
14. Follow-up and tracking of patient address, vital status, additional questionnaire administration, medical updates
15. Employ methods to obtain high response rates for study participation, including among minorities and other underserved populations
16. Medical record retrieval and abstraction into desired abstraction platforms
17. Biospecimen (blood, tissue, urine, nails, hair, other) collection and storage
18. Measurement of food intake and nutrition through questionnaire administration
19. Measurement of nutrition and metabolic processes through biological sample collection and clinical level quality control based lab processing using a contracted lab
20. Provider and media interventions to target specific and/or underserved populations
21. Household (pesticide, air pollutants, diesel contamination) exposure risk assessment
22. Expert witnesses in a variety of areas (pesticide and diesel contamination)
* Identification can be population-based and be designed to over-sample based upon specific criteria such as: clinical or pathologic disease characteristics, race/ethnicity, area of residence, age, gender, residence in disadvantaged census tracts, type of treating facility, etc. It is also possible to either include patients from a broad geographic area or restrict patients to those living in the Greater Bay Area. Disease definition and patient inclusion criteria will dictate the size of the geographic area that can be covered and whether rapid case ascertainment is required.
Back to Guide for Collaborators home page.
NCCC conducts innovative and dynamic cancer research and outreach programs that explore areas with significant impact on reducing the cancer burden. For more information about our research programs or possible collaborations, contact Tim Radak (tradak@nccc.org, 510-608-5026) or Ingrid Oakley-Girvan (ioakley@nccc.org, 510-608-5045).
|